Differences Between Sorafenib and Lenvatinib Treatment from Genetic and Clinical Perspectives for Patients with Hepatocellular Carcinoma

BACKGROUND: The aim of this work was to systematically compare the differences between sorafenib and lenvatinib for patients with hepatocellular carcinoma (HCC) from genetic and clinical perspectives. MATERIAL/METHODS: The mRNA and miRNA sequencing information of patients with HCC treated with eithe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Xiao, Bo, Cui, Mingxuan, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059551/
https://www.ncbi.nlm.nih.gov/pubmed/35473892
http://dx.doi.org/10.12659/MSM.934936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059551/
https://www.ncbi.nlm.nih.gov/pubmed/35473892
http://dx.doi.org/10.12659/MSM.934936

Ejemplares similares